• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR MARATHON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR MARATHON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 105-5056
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Infarction, Cerebral (1771); Foreign Body In Patient (2687)
Event Date 01/10/2018
Event Type  Injury  
Manufacturer Narrative
The device involved in the event has not been returned for evaluation; therefore, the event cause could not be determined.The distal marker band remains in the patient's distal cerebral artery.Communication has been made for the device return and a supplemental will be sent once the device is retuned and evaluated.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received report that during brain tumor (cerebellar infarction) / embolization, the marathon microcatheter and the mirage guidewire were navigated to the treating location, however, the marker of the marathon microcatheter could not be seen on image.The marathon was removed from the patient, and the physician noticed the marker was missing.New device was used to continue with the procedure.The procedure was completed without further issues, but a foreign material that appeared like the marker was identified on an image of the posterior interior cerebral artery (pica) distal.The patient was reported to have been asymptomatic.The patient was undergoing embolization of a brain tumor (cerebellar infarction).The physician commented the marker might have been disengaged when he re-inserted the marathon microcatheter through y connector as the marathon microcatheter was bent upon insertion at the time of the initial insertion.Information regarding customer shaping the catheter tip.Preparation of devices according to ifu, and maintaining continuous flush were not available.The catheter was briefly checked prior to use and no damage was found.The details of the patient¿s vasculature were not disclosed by the customer.
 
Manufacturer Narrative
Updated describe event or problem.Updated evaluation codes.Summary of investigation: the marathon micro catheter was returned for analysis.No damages or irregularities were found with the marathon micro catheter hub.No bends or kinks were found with the marathon micro catheter body.The marathon micro catheter distal end does not appear to be bent or shaped.Approximately 0.6 mm of the distal tip and marker band were found missing from the marathon micro catheter.It is possible this segment remains within the patient.The tubing material at the broken end exhibited with jagged edges and stretching.The marathon micro catheter was flushed, water and blood exited from the distal end.No other anomalies were observed.Based on the device analysis and reported information, the customer¿s report of "marker band dislodged" was confirmed as the distal marker band and tip of the marathon micro catheter was found to be separated and missing.The broken end exhibited plastic deformation of the tubing material (jagged edges and stretching) which indicates that catheter separated when pulled and exceeding the tensile strength of the tubing material.It is possible the tip became separated during re-insertion of the marathon micro catheter through y connector as the tip was reported to be bent.It is not known if a guidewire, stylet, and/or introducer sheath were used to assist with the insertion of the micro catheter in to the hub.All products are 100% inspected for damages and irregularities during manufacture.Therefore, manufacturing has been ruled out as a potential cause.As noted in the marathon ifu (instructions for use): ¿inspect the catheter prior to use to verify that it is undamaged.To assist with insertion of the microcatheter in to the hub, the following accessories may be used: a guidewire, stylet, and/or introducer sheath.Advance the stylet or guidewire through the catheter, keeping the catheter body straight; close the one-way stop-cock; loosen the hemostatic valve; introduce the catheter through the hemostatic adapter; tighten the valve around the catheter to prevent backflow, but allowing some movement through the valve by the catheter; open the one-way stop-cock; advance the catheter such that the stylet or guidewire remains in the guiding catheter; once the catheter has been advanced to the end of the guiding catheter, if using a stylet withdraw the stylet from the catheter.In addition, ¿never advance or withdraw an intraluminal device against resistance until the cause of the resistance is determined by fluoroscopy.Excessive force against resistance may result in damage to the device or vessel perforation.¿ if information is provided in the future, a supplemental report will be issued.
 
Event Description
Received additional information stating that the exact location of where the microcatheter was to be delivered was not available, but the physician was going to deliver the catheter somewhere within posterior circulation.The physician commented that he felt the catheter was caught by the y connector, and he was thinking that the marker was detached there and moved as flushing and administration of contrast medium.Also, it was reported that it could not be confirmed if only the marker was separated or the distal end (with marker) of the microcatheter was separated, but the marker was found located at the distal end of pica, and the physician was thinking that the separated piece caused the cerebellar infarction.The physician was planning to use nbca but not actually used for the procedure due to the issue.The physician noticed the issue before using nbca, and he used another device to continue.The patient suffered a cerebellar infarction due to the issue, and current condition is reported as not recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MARATHON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9492753836
MDR Report Key7235274
MDR Text Key98833400
Report Number2029214-2018-00073
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K093750
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/13/2020
Device Model Number105-5056
Device Lot NumberA515731
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/30/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2018
Date Device Manufactured08/29/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Disability;
-
-